Stiolto Respimat 3.124 ug/1 (Tiotropium Bromide and Olodaterol SPRAY, METERED) 3.124 ug/1

Stiolto Respimat 3.124 ug/1 is a combination inhaler containing tiotropium bromide and olodaterol. It is used for managing chronic obstructive pulmonary disease (COPD) symptoms. This metered spray helps improve breathing and reduce airway inflammation.

Strength

3.124 ug/1

Pack Size

1 CARTRIDGE in 1 CARTON (0597-0155-61) / 60 SPRAY, METERED in 1 CARTRIDGE

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Stiolto Respimat 3.124 ug/1 is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). This combination medication helps to relax the airways, making it easier to breathe. It is often prescribed for individuals who require both bronchodilation and long-term symptom management. People often ask, 'What is Stiolto Respimat used for?' It is designed to improve lung function and reduce the frequency of COPD exacerbations.

Side Effects

Common effects of Stiolto Respimat 3.124 ug/1 may include dry mouth, throat irritation, and cough. Some users might experience headaches or dizziness. These effects are generally mild and temporary. If any effects persist or worsen, it is advisable to consult a healthcare provider.

Precautions & Warnings

Stiolto Respimat 3.124 ug/1 should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. This medication should not be used for acute symptoms or asthma attacks. Always store the inhaler properly and keep it out of reach of children.

Avoid Interactions

Stiolto Respimat 3.124 ug/1 may interact with other medications, including beta-blockers and certain antihistamines. It is important to inform your healthcare provider about all medications you are taking. Avoid using this inhaler with other long-acting beta-agonists unless directed by a healthcare professional.

Frequently Asked Questions

Stiolto Respimat 3.124 ug/1 is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) to improve breathing and reduce airway inflammation.

Follow the instructions provided by your healthcare provider. Typically, it involves inhaling the medication as directed, usually once or twice daily.

Common side effects may include dry mouth, throat irritation, cough, headaches, and dizziness. These effects are usually mild and temporary.

Stiolto Respimat is not indicated for the treatment of asthma. It is specifically designed for the maintenance treatment of COPD.

Store the inhaler at room temperature and keep it away from moisture and heat. Always keep it out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.